Company Active LTD

Company profile

Vitrue Ltd

Employee Wellbeing & Desk Assessments | Vitrue Health

Vitrue Ltd is a UK company with status active founded in 2017.

CRN
10775942
Founded
2017
Age
9

Overview

Legal name
VITRUE LTD
Region
Unknown
Registered address
27 CORSHAM STREET
27 CORSHAM STREET
LONDON
ENGLAND
N1 6DR
Insolvency history
No

Latest accounts

Financial period: 1 Jun 2024 to 31 May 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
18

Company events

Reference milestones and recent Companies House filing stream events.

9 events
28 Feb
2027

Accounts due

Accounts Due

Next accounts due date

27 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Jun
2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzUyOTUwMTIyNGFkaXF6a2N4

Published 30 Jun 2026 15:38

13 Sep
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 May
2025

Accounts filed

Accounts

Last accounts made up date

25 Feb
2025

Accounts With Accounts Type Unaudited Abridged

Accounts Analysed

AA | Transaction MzQ1NjMyNTY5NmFkaXF6a2N4

Published 25 Feb 2025 12:10

21 Feb
2025

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQ1NjAwNTc4NmFkaXF6a2N4

Published 21 Feb 2025 04:59

22 Oct
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQ0MDQ5NjcwMWFkaXF6a2N4

Published 22 Oct 2024 02:30

17 May
2017

Incorporated

Inception

Company registered at Companies House

Public funding

6 awards
First funded
2018
Funded years
2018, 2019, 2020
Age at first award
0 years

Projects

2020 Collaborative R&D Lead participant

Enabling non invasive treatment of musculoskeletal pathologies in a new remote healthcare world

1 Nov 2020 to 30 Jun 2021

Awarded
£138,611
Total cost £173,264

This project will combine and build upon cutting edge technical and clinical innovations from a fast growth musculoskeletal health diagnostics startup company and a world leading innovator in non invasive musculoskeletal interventions. The COVID-19 pandemic has caused immense disruption across industries, none more so than in healthcare. The effects of th...

2020 Feasibility Studies Lead participant

Avoiding the onslaught of musculoskeletal conditions caused by Covid-19 isolation using computer vision based musculoskeletal diagnostic tools

1 Jun 2020 to 31 Mar 2021

Awarded
£74,242
Total cost £74,242

The Covid-19 crisis represents the largest challenge to our health system in seventy years. The vast majority of efforts are rightly focused on saving lives. However it is crucial that we mitigate and prepare for the medium and long term knock on effects of the crisis. One of these effects in the massive increase in musculoskeletal problems such as back p...

2020 Feasibility Studies Lead participant

33502 Medici: Augmented Quantitative Motor Function Assessment

1 Jun 2020 to 30 Nov 2020

Awarded
£70,374
Total cost £70,374

no public description

2019 Collaborative R&D Lead participant

Medici: Augmented Quantitative Motor Function Assessment

1 Oct 2019 to 30 Jun 2021

Awarded
£264,485
Total cost £377,836

"This project is a collaboration between a UK technology company and a leading UK university (Vitrue Health, Oxford University). Its vision is to overhaul the way we assess musculoskeletal conditions in clinical settings. This form of assessment is used across a wide array of the most common and costly conditions in healthcare and is predictive of morbidi...

2019 Collaborative R&D Lead participant

Vitrue Health

1 Apr 2019 to 31 Mar 2020

Awarded
£50,000
Total cost £50,000

"Functional health information is a powerful tool enabling clinicians to maintain patient quality of life, but it is let down by imperfect assessment tools that are subjective, have poor repeatability and are insensitive to incremental change. Vitrue's computer vision based system removes these issues by accurately measuring motor function and automating ...

2018 Feasibility Studies Lead participant

Vitrue Autonomous Functional Assessment Feasibility Study

1 Feb 2018 to 31 Jan 2019

Awarded
£52,500
Total cost £75,000

"In modern healthcare, not only must we focus on prolonging a person's life, but also on maintaining the quality of that life. The opportunity this project addresses is the radical improvement of functional assessment, a key step in measuring and managing a range of conditions such as frailty, stroke, risk of falls and musculoskeletal disorders affecting ...

Product types

Collaborative R&D Feasibility Studies